Citation Impact
Citing Papers
T cell metabolism drives immunity
2015
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
2009
Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells
2012
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Optimal Dissociation Methods Differ for N - and O -Glycopeptides
2020 StandoutNobel
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
2009
Ursolic Acid Inhibits STAT3 Activation Pathway Leading to Suppression of Proliferation and Chemosensitization of Human Multiple Myeloma Cells
2007
IL-7 Enhances Thymic Human T Cell Development in “Human Immune System” Rag2−/−IL-2Rγc−/− Mice without Affecting Peripheral T Cell Homeostasis
2009
Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the O-glycoproteome by inducible expression in isogenic cell lines
2018
Exploring Regulation of Protein O-Glycosylation in Isogenic Human HEK293 Cells by Differential O-Glycoproteomics
2019
De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium
2017
Hallmarks of Cancer: The Next Generation
2011 Standout
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Overexpression of Phosphorylated-STAT3 Correlated with the Invasion and Metastasis of Cutaneous Squamous Cell Carcinoma
2005
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB–regulated antiapoptotic and cell survival gene products in human multiple myeloma cells
2006
EGFR Antagonists in Cancer Treatment
2008 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
Combining immunotherapy and targeted therapies in cancer treatment
2012
Oncogenic kinase signalling
2001 StandoutNature
Anaplastic lymphoma kinase proteins in growth control and cancer
2004
Advances toward mapping the full extent of protein site-specific O-GalNAc glycosylation that better reflects underlying glycomic complexity
2019
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
2006
Sensitizing Anthrax Lethal Toxin-resistant Macrophages to Lethal Toxin-induced Killing by Tumor Necrosis Factor-α
2003 StandoutNobel
Regulatory T Cells in Cancer
2010
Analysis of Mammalian O-Glycopeptides—We Have Made a Good Start, but There is a Long Way to Go
2017
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
TOR, a Central Controller of Cell Growth
2000 Standout
Angiogenesis and antiangiogenic therapy in hematologic malignancies
2006
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
The Epigenomics of Cancer
2007 Standout
STAT3 as a central mediator of neoplastic cellular transformation
2006
Serine phosphorylation of STATs
2000
Epigenetics in Cancer
2008 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and mdulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts
2008 Nobel
The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy
2005
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis
2004
Revealing the human mucinome
2022 StandoutNobel
Regulation of JAK–STAT signalling in the immune system
2003
N- and O-glycosylation Analysis of Human C1-inhibitor Reveals Extensive Mucin-type O-Glycosylation
2017
Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development In Vivo
2014
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Activation of Stat‐3 as one of the early events in tobacco chewing‐mediated oral carcinogenesis
2002
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Calyculin A Sensitive Protein Phosphatase Is Required for Bacillus anthracis Lethal Toxin Induced Cytotoxicity
2002
Prospects for the use of NK cells in immunotherapy of human cancer
2007
Origin and physiological roles of inflammation
2008 StandoutNature
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR
2000
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Structural basis of mammalian mucin processing by the human gut O-glycopeptidase OgpA from Akkermansia muciniphila
2020
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Activation of STAT proteins and growth control
2001
Cytokine Signaling in 2002
2002 Standout
Selective Induction of Apoptosis by Histone Deacetylase Inhibitor SAHA in Cutaneous T-Cell Lymphoma Cells: Relevance to Mechanism of Therapeutic Action
2005
Gastric cancer: adding glycosylation to the equation
2013
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A
2003
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Tumor Angiogenesis
2008 Standout
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
ISOGlyP: de novo prediction of isoform-specific mucin-type O-glycosylation
2020
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming
2006
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Cell surface protein glycosylation in cancer
2013
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations
2010
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation
2006 StandoutNobel
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival
2003
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
A New Searching Strategy for the Identification of O-Linked Glycopeptides
2019
SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile
2018
Spermidine in health and disease
2018 StandoutScience
Status Report on the High-Throughput Characterization of Complex Intact O-Glycopeptide Mixtures
2018
Engineering Orthogonal Polypeptide GalNAc-Transferase and UDP-Sugar Pairs
2019 StandoutNobel
Capsaicin Is a Novel Blocker of Constitutive and Interleukin-6–Inducible STAT3 Activation
2007
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
2009
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Mapping the O‐glycoproteome using site‐specific extraction of O‐linked glycopeptides (EXoO)
2018
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells
2005
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Differential Effects of Interleukin-2 and Interleukin-15 versus Interleukin-21 on CD4+ Cutaneous T-Cell Lymphoma Cells
2008
The benefits of hybrid fragmentation methods for glycoproteomics
2018
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
IL-23 and Autoimmunity: New Insights into the Pathogenesis of Inflammatory Bowel Disease
2008
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice
2011 StandoutNobel
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.
2001
Recent Advances in Glycoproteomic Analysis by Mass Spectrometry
2019
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Guggulsterone, a Farnesoid X Receptor Antagonist, Inhibits Constitutive and Inducible STAT3 Activation through Induction of a Protein Tyrosine Phosphatase SHP-1
2008
Chemical Glycoproteomics
2016 StandoutNobel
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses
2012 StandoutNobel
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
2008
Works of Anders Woetmann being referenced
Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma
2016
Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity
2012
γc-Signaling Cytokines Induce a Regulatory T Cell Phenotype in Malignant CD4+ T Lymphocytes
2008
Malignant Cutaneous T-Cell Lymphoma Cells Express IL-17 Utilizing the Jak3/Stat3 Signaling Pathway
2011
Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells
1999
Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNα
2004
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma
2006
Activated human CD4+ T cells express transporters for both cysteine and cystine
2012
The effect of short-chain fatty acids on human monocyte-derived dendritic cells
2015
In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3
2004
Bi-phasic Effect of Interferon (IFN)-α
2003
FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival
2007
Constitutive STAT3 Activation in Intestinal T Cells from Patients with Crohn's Disease
2003
Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
2011
Characterizing the O-glycosylation landscape of human plasma, platelets, and endothelial cells
2017
Cancer Cells Become Susceptible to Natural Killer Cell Killing after Exposure to Histone Deacetylase Inhibitors Due to Glycogen Synthase Kinase-3–Dependent Expression of MHC Class I–Related Chain A and B
2005
Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3
1999
STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes
2006
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
2013
THE ROLE OF CASPASE 3 AND BclxLIN THE ACTION OF INTERLEUKIN 7 (IL-7): A SURVIVAL FACTOR IN ACTIVATED HUMAN T CELLS
1998